Evidence map›Paper›PMID 38858197›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[Application and progress of ablation therapy for large liver cancer].

Z Wang, Z Wang, S Wang, Y Q Zhang, X L Yu

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Z WangDepartment of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China Chinese PLA Medical School, Beijing 100039, China.
Z WangDepartment of Interventional Ultrasound, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
S WangDepartment of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China Chinese PLA Medical School, Beijing 100039, China.
Y Q ZhangDepartment of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China Chinese PLA Medical School, Beijing 100039, China.
X L YuDepartment of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China.

Funding

National Natural Science Foundation of China 82172027
6 · The paper itself

Abstract

Primary liver cancer is one of the most common malignant tumors. A liver tumor is defined as a large cancer when its diameter is ≥5 cm. Resection surgical therapy can be performed only on a small portion of large cancers because of its own features. As a result, non-resection surgical therapy has become a hot and difficult issue of widespread concern. In recent years, with the development of ablation technology, research on the use of ablation alone and ablation combined with other modalities for the treatment of large liver cancer has continued to deepen, and good clinical results have been achieved. Although there are many reports on ablation treatment for large liver cancer, there are currently no standardized treatment guidelines, and there are still controversies about treatment strategies. This article reviews the development of ablation therapy, the current status of single and combined ablation therapy, the prevention of related complications, and other aspects of large liver cancer.

Indexed as

Catheter AblationLiver NeoplasmsAblation TechniquesCarcinoma, HepatocellularHumansRadiofrequency AblationAblationComplicationsGiant hepatocellular carcinomaHepatocellular carcinomaReviewTherapeutic

Identifiers

PMID38858197
PMCPMC12898968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.